Invention Grant
- Patent Title: CD1a antibodies and uses thereof
-
Application No.: US17450283Application Date: 2021-10-07
-
Publication No.: US11746154B2Publication Date: 2023-09-05
- Inventor: Florian Winau , Oleg V. Kovalenko , Chew Shun Chang , Di Wu , Nicholas Andrew Marze , Shian-Huey Chiang
- Applicant: Pfizer Inc. , Children's Medical Center Corporation
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.,Children's Medical Center Corporation
- Current Assignee: Pfizer Inc.,Children's Medical Center Corporation
- Current Assignee Address: US NY New York; US MA Boston
- Agency: Norton Rose Fulbright US LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C12N5/02 ; C12N5/20 ; C12N15/00 ; C07K16/00 ; C07K16/46 ; C07H21/04 ; C07K16/28 ; A61P17/00
Abstract:
Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
Public/Granted literature
- US20220112291A1 CD1a ANTIBODIES AND USES THEREOF Public/Granted day:2022-04-14
Information query
